A multicenter, randomized, observer-blinded, single-dose, placebo-controlled, sequential cohort study of the efficacy and safety of Xen2174 in subjects following bunionectomy surgery.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2012
At a glance
- Drugs XEN 2174 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms Amendment1
- 01 Aug 2012 Status changed from recruiting to completed as reported by EudraCT.
- 29 Dec 2011 New trial record